Stock Events

Harmony Biosciences 

$31.1
36
-$0.35-1.11% Today

Statistics

Day High
31.4
Day Low
30.94
52W High
46.77
52W Low
18.61
Volume
8,222
Avg. Volume
286,875
Mkt Cap
1.82B
P/E Ratio
12.59
Dividend Yield
-
Dividend
-

Earnings

22FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0.13
0.57
1
1.44
Expected EPS
0.48
Actual EPS
0.73

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HRMY. It's not an investment recommendation.

Analyst Ratings

41.43$Average Price Target
The highest estimate is $59.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
0%
Sell
29%

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Medicinal and Botanical Manufacturing
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
Show more...
CEO
Employees
150
Country
US
ISIN
US4131971040

Listings